{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:15:01Z","timestamp":1777356901461,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00296-013-2668-5","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T09:28:31Z","timestamp":1358933311000},"page":"1943-1950","source":"Crossref","is-referenced-by-count":27,"title":["Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients"],"prefix":"10.1007","volume":"33","author":[{"given":"Hadi","family":"Poormoghim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza Salek","family":"Moghadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maziar","family":"Moradi-Lakeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrzad","family":"Jafarzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnam","family":"Asadifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Ghelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Andalib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"key":"2668_CR1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.autrev.2008.06.010","volume":"7","author":"M Koenig","year":"2008","unstructured":"Koenig M, Dieude M, Senecal JL (2008) Predictive value of antinuclear antibodies: the lessons of systemic sclerosis autoantibodies. Autoimmun Rev 7:588\u2013593","journal-title":"Autoimmun Rev"},{"key":"2668_CR2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","volume":"35","author":"VD Steen","year":"2005","unstructured":"Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35:35\u201342","journal-title":"Semin Arthritis Rheum"},{"key":"2668_CR3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"UA Walker","year":"2007","unstructured":"Walker UA, Tyndall A, Czirj\u00e1k L, Denton C, Farge-Bancel D, Kowal-Bielecka O et al (2007) Clinical risk assessment of organ manifestation in systemic sclerosis: a report from the EULAR Scleroderma Trial and Research group database. Ann Rheum Dis 66:754\u2013763","journal-title":"Ann Rheum Dis"},{"key":"2668_CR4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jbspin.2006.01.022","volume":"73","author":"O Meyer","year":"2006","unstructured":"Meyer O (2006) Prognostic markers for systemic sclerosis. Joint Bone Spine 73:490\u2013494","journal-title":"Joint Bone Spine"},{"key":"2668_CR5","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","volume":"9","author":"M Koenig","year":"2007","unstructured":"Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Sen\u00e9cal JL (2007) Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 9:R78. doi: 10.1186\/ar2276","journal-title":"Arthritis Res Ther"},{"key":"2668_CR6","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets, and patogenesis. J Rheumatol 15:202\u2013205","journal-title":"J Rheumatol"},{"key":"2668_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/art.21538","volume":"54","author":"S Trad","year":"2006","unstructured":"Trad S, Amoura Z, Beigelman C, Haroche J, Costedoat N, Du Bountin LTH et al (2006) Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interestial lung disease. Arthritis Rheum 54:181\u2013191","journal-title":"Arthritis Rheum"},{"key":"2668_CR8","first-page":"51","volume-title":"Systemic sclerosis","author":"TA Medsger Jr","year":"1996","unstructured":"Medsger TA Jr, Steen VD (1996) Classification, prognosis. In: Clements PJ, Furst DE (eds) Systemic sclerosis. Williams & Wilkins, Baltimore, MD, pp 51\u201364"},{"key":"2668_CR9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1749-6632.2009.04735.x","volume":"1173","author":"U Sack","year":"2009","unstructured":"Sack U, Conrad K, Csernok E, Frank I, Hiepe F, Krieger T et al (2009) Autoantibody detection using indirect immunofluorescence on HEp-2 cells. Ann N Y Acad Sci 1173:166\u2013173","journal-title":"Ann N Y Acad Sci"},{"key":"2668_CR10","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2622","volume":"11","author":"K Hanke","year":"2009","unstructured":"Hanke K, Dahnrich C, Bruckner C, Huscher D, Becker M, Janssen A et al (2009) Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort. Arthritis Res Ther 11:R28","journal-title":"Arthritis Res Ther"},{"key":"2668_CR11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","volume":"81","author":"C Ferri","year":"2002","unstructured":"Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelstssi C, La Montagna G et al (2002) Systemic sclerosis, demographic, clinical, and serologic features and survival in 1012 Italian patients. Medicine 81:139\u2013159","journal-title":"Medicine"},{"key":"2668_CR12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0889-857X(03)00022-X","volume":"29","author":"MD Mayes","year":"2003","unstructured":"Mayes MD (2003) Scleroderma epidemiology. Rheum Dis Clin North Am 29:239\u2013254","journal-title":"Rheum Dis Clin North Am"},{"key":"2668_CR13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/rheumatology\/37.7.750","volume":"37","author":"S Jacobsen","year":"1998","unstructured":"Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750\u2013755","journal-title":"Br J Rheumatol"},{"key":"2668_CR14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/art.10561","volume":"47","author":"DH Solomon","year":"2002","unstructured":"Solomon DH, Kavanaugh AJ, Schur PH (2002) The American College of Rheumatology Ad Hoc Committee on immunologic testing guidelines evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 47:434\u2013444","journal-title":"Arthritis Rheum"},{"key":"2668_CR15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/rheumatology\/keg170","volume":"42","author":"R Hesselstrand","year":"2003","unstructured":"Hesselstrand R, Scheja A, Shen GO, Wiik A, Akesson AT (2003) The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology 42:534\u2013540","journal-title":"Rheumatology"},{"key":"2668_CR16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/art.1780370214","volume":"37","author":"D Vazquez-Abad","year":"1994","unstructured":"Vazquez-Abad D, Wallace S, Senecal JL, Joyal F, Roussin A, Earnshaw WC, Rothfield N (1994) Anticentromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen. Arthritis Rheum 37:248\u2013252","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2668_CR17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/anr.1780320109","volume":"32","author":"LJ McNeilage","year":"1989","unstructured":"McNeilage LJ, Youngchaiyud U, Whittingham S (1989) Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 32(1):54\u201360","journal-title":"Arthritis Rheum"},{"key":"2668_CR18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.1780310207","volume":"31","author":"DV Steen","year":"1988","unstructured":"Steen DV, Powell LD, Medsger AT (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31:196\u2013203","journal-title":"Arthritis Rheum"},{"key":"2668_CR19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1378\/chest.114.3.801","volume":"114","author":"EL Greidinger","year":"1998","unstructured":"Greidinger EL, Flaherty KT, White B, Rosen A, Wigley FM, Wise RA (1998) African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest 114:801\u2013807","journal-title":"Chest"},{"key":"2668_CR20","first-page":"43","volume":"48","author":"RM Bernstein","year":"1982","unstructured":"Bernstein RM, Steigerwald JC, Tan EM (1982) Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Immunol 48:43\u201351","journal-title":"Clin Exp Immunol"},{"key":"2668_CR21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.1780290409","volume":"29","author":"AM Stupi","year":"1986","unstructured":"Stupi AM, Steen VD, Owen GR, Barnes EL, Rodnan GP, Medsger TA Jr (1986) Pulmonary hypertension (PTH) in the CREST syndrome variant of progressive sclerosis (PSS). Arthritis Rheum 29:515\u2013524","journal-title":"Arthritis Rheum"},{"key":"2668_CR22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/40.10.1157","volume":"40","author":"VJ Tormey","year":"2001","unstructured":"Tormey VJ, Bunn CC, Denton CP, Black CM (2001) Anti-fibrillarin antibodies in systemic sclerosis. Rheumatology 40:1157\u20131162","journal-title":"Rheumatology"},{"key":"2668_CR23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/art.1780350114","volume":"35","author":"Y Okano","year":"1992","unstructured":"Okano Y, Steen VD, Medsger ATA Jr (1992) Autoantibody to U3 nucleolar ribonucleoprotein (fibrilliarin) in patients with systemic sclerosis. Arthritis Rheum 35:95\u2013100","journal-title":"Arthritis Rheum"},{"key":"2668_CR24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/art.1780310409","volume":"31","author":"G Primer","year":"1988","unstructured":"Primer G, Steen VD, Penning CA, Medsger T, Tan EM (1988) Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis. Arthritis Rheum 31:525","journal-title":"Arthritis Rheum"},{"key":"2668_CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.1780370111","volume":"37","author":"M Kuwana","year":"1994","unstructured":"Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M (1994) Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 37:75\u201383","journal-title":"Arthritis Rheum"},{"key":"2668_CR26","first-page":"477","volume":"24","author":"G Harvey","year":"1997","unstructured":"Harvey G, Black C, Maddison P, McHugh N (1997) Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives. J Rheumatol 24:477\u2013484","journal-title":"J Rheumatol"},{"key":"2668_CR27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/clin.1998.4591","volume":"89","author":"M Chang","year":"1998","unstructured":"Chang M, Wang R, Yangco D, Sharp G, Komatireddy G, Hoffman R (1998) Analysis of autoantibodies against RNA polymerases using immunoaffinity-purified RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay. Clin Immunol Immunopath 89:71\u201378","journal-title":"Clin Immunol Immunopath"},{"key":"2668_CR28","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/rheumatology\/kep290","volume":"48","author":"T Satoh","year":"2009","unstructured":"Satoh T, Ishikawa O, Ihn H, Endo H, Kawaguchi Y, Sasaki T et al (2009) Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunoassay. Rheumatology 48:1570\u20131574","journal-title":"Rheumatology"},{"key":"2668_CR29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/rheumatology\/37.1.15","volume":"37","author":"CC Bunn","year":"1998","unstructured":"Bunn CC, Denton CP, Shi-Wen X, Knight C, Black CM (1998) Anti-RNA polymerase and other autoantibody specification in systemic sclerosis. Br J Rheumatol 37:15\u201320","journal-title":"Br J Rheumatol"},{"key":"2668_CR30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.7326\/0003-4819-119-10-199311150-00007","volume":"119","author":"Y Okano","year":"1993","unstructured":"Okano Y, Steen VD, Medsger TA Jr (1993) Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 119:1005\u20131013","journal-title":"Ann Intern Med"},{"key":"2668_CR31","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/rheumatology\/kep215","volume":"48","author":"SI Nihtyanova","year":"2009","unstructured":"Nihtyanova SI, Parker JC, Black CM, Bunn CC, Denton CP (2009) A longitudinal study of anti-RNA polymerase III antibody level in systemic sclerosis. Rheumatology 48:1218\u20131221","journal-title":"Rheumatology"},{"key":"2668_CR32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/art.1780340405","volume":"34","author":"RD Altman","year":"1991","unstructured":"Altman RD, Medsger TA Jr, Bloch DA, Michel BA (1991) Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 34:403\u2013413","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2668_CR33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/berh.1999.0080","volume":"14","author":"PJ Maddison","year":"2000","unstructured":"Maddison PJ (2000) Mixed connective tissue disease: overlap syndromes. Baillieres Best Pract Res Clin Rheumatol 14(1):111\u2013124","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"key":"2668_CR34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2249.1999.00961.x","volume":"117","author":"H Ihn","year":"1999","unstructured":"Ihn H, Yamane K, Yazawa N, Kubo M, Fujimoto M, Sato S et al (1999) Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis. Clin Exp Immunol 117:383\u2013387","journal-title":"Clin Exp Immunol"},{"issue":"49","key":"2668_CR35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","volume":"15","author":"JD Reveille","year":"2003","unstructured":"Reveille JD, Solomon DH (2003) American College of Rheumatology, Ad Hoc Committee on immunological testing guidelines evidence-based guidelines for the use of immunologic laboratory tests: anti-centromere, Scl-70 and nucleolar antibodies. Arthritis Rheum 15(49):399\u2013412","journal-title":"Arthritis Rheum"},{"key":"2668_CR36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.61.2.121","volume":"61","author":"T Dick","year":"2002","unstructured":"Dick T, Mierau R, Bartz-Bazzanaella P (2002) Coexistence of antitopoisomeras and anticentromere antibodies in patients with systemic sclerosis. Ann Rheum Dis 61:121\u2013127","journal-title":"Ann Rheum Dis"},{"key":"2668_CR37","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.61.9.842","volume":"61","author":"M Kuwana","year":"2002","unstructured":"Kuwana M, Kimura K, Hirakata M (2002) Differences in autoantibody response to Th\/To between systemic sclerosis and other autoimmune diseases. Ann Rheum Dis 61:842\u2013846","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2668-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-013-2668-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-013-2668-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:21:44Z","timestamp":1559042504000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-013-2668-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2668"],"URL":"https:\/\/doi.org\/10.1007\/s00296-013-2668-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}